Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery

By MedImaging International staff writers
Posted on 20 May 2026
Image: The measurement, known as diaphragmatic dome height (DDH), enables simple early identification of high-risk postsurgical lung cancer patients with obstructive ventilatory disorder (image credit: 123RF)
Image: The measurement, known as diaphragmatic dome height (DDH), enables simple early identification of high-risk postsurgical lung cancer patients with obstructive ventilatory disorder (image credit: 123RF)

Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure, clinicians still lack simple and reliable tools to predict survival after resection in routine practice. Many existing assessments are complex or require specialized resources, limiting their use in standard preoperative workups. A new study shows that a measurement derived from standard preoperative chest X-rays could help identify higher-risk patients and guide treatment planning.

The measurement, called diaphragmatic dome height (DDH), reflects the position and function of the diaphragm. Investigators at Kindai University Hospital and Kindai University (Osaka, Japan) evaluated whether preoperative DDH could predict outcomes after lobectomy in patients with lung cancer and obstructive ventilatory disorder. The study is the first to establish DDH as a practical prognostic marker that is low cost and widely accessible.

In this retrospective analysis, 302 patients with lung cancer and obstructive ventilatory disorder who underwent lobectomy between 2017 and 2024 were assessed. DDH was measured on chest radiographs obtained one month before surgery. Patients were stratified into low- and high-DDH groups, and survival outcomes were tracked.

Lower DDH was linked to worse long-term survival and more respiratory-related deaths. Three-year overall survival was 70% in the low-DDH group compared with 85% in the high-DDH group, and disease-specific survival was also reduced among patients with lower DDH. DDH remained an independent prognostic factor after adjustment for tumor stage and pulmonary function, while conventional pulmonary function testing did not show a strong association with survival.

The authors noted that DDH may capture aspects of diaphragmatic dysfunction not fully reflected by standard tests, offering additional prognostic insight. Because chest radiographs are already central to preoperative evaluation, incorporating DDH does not add cost, time, or patient burden and may support targeted respiratory rehabilitation and optimized perioperative care. The findings were published on April 21, 2026, in the International Journal of Clinical Oncology.

“By evaluating DDH using routine chest radiographs, postoperative prognosis can be predicted without the need for additional examinations. This enables early and simple identification of high-risk patients and allows clinicians to tailor treatment strategies accordingly.” said Masaya Noguchi, physical therapist at Kindai University Hospital.

 "In the future, incorporating DDH into clinical practice may allow for more efficient and personalized treatment strategies," says Noguchi. "It also has the potential to improve long-term outcomes and quality of life for patients."

Related Links
Kindai University

Ultrasound Table
Women’s Ultrasound EA Table
Digital Color Doppler Ultrasound System
MS22Plus
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Multi-Use Ultrasound Table
Clinton

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.